Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Grade ≥3 hematologic toxicities were uncommon (anemia 6.1%, neutropenia 5.2%), and non-hematologic adverse events were rare. The absence of bone-modifying agents was the strongest predictor of ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Adelaide newsreader Will McDonald has managed his aggressive stage 4 prostate cancer for six years now, although he knows the ...
An update from Telix Pharmaceuticals ( (AU:TLX) ) is now available.
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...
7d
Longevity doctor shares screening tests to detect cancer before symptoms show: ‘They buy you time’
Sometimes waiting for symptoms to appear may be too late when it comes to detecting cancer. Dr Vass shares tests that can help with early detection. | Health ...
Graham Heron from Dorset urges UK men to get PSA tests for early prostate cancer detection, credits Dorchester Hospital and DCCF for vital support.
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results